nodes	percent_of_prediction	percent_of_DWPC	metapath
Meropenem—Sweating—Doxorubicin—breast cancer	0.000208	0.000208	CcSEcCtD
Meropenem—Urticaria—Paclitaxel—breast cancer	0.000208	0.000208	CcSEcCtD
Meropenem—Hyperhidrosis—Capecitabine—breast cancer	0.000208	0.000208	CcSEcCtD
Meropenem—Oedema peripheral—Epirubicin—breast cancer	0.000208	0.000208	CcSEcCtD
Meropenem—Hypotension—Docetaxel—breast cancer	0.000208	0.000208	CcSEcCtD
Meropenem—Abdominal pain—Paclitaxel—breast cancer	0.000207	0.000207	CcSEcCtD
Meropenem—Body temperature increased—Paclitaxel—breast cancer	0.000207	0.000207	CcSEcCtD
Meropenem—Hepatobiliary disease—Doxorubicin—breast cancer	0.000206	0.000206	CcSEcCtD
Meropenem—Epistaxis—Doxorubicin—breast cancer	0.000205	0.000205	CcSEcCtD
Meropenem—Anorexia—Capecitabine—breast cancer	0.000205	0.000205	CcSEcCtD
Meropenem—Vomiting—Mitoxantrone—breast cancer	0.000204	0.000204	CcSEcCtD
Meropenem—Vomiting—Irinotecan—breast cancer	0.000204	0.000204	CcSEcCtD
Meropenem—Immune system disorder—Methotrexate—breast cancer	0.000204	0.000204	CcSEcCtD
Meropenem—Dizziness—Fluorouracil—breast cancer	0.000204	0.000204	CcSEcCtD
Meropenem—Agranulocytosis—Doxorubicin—breast cancer	0.000203	0.000203	CcSEcCtD
Meropenem—Rash—Irinotecan—breast cancer	0.000203	0.000203	CcSEcCtD
Meropenem—Rash—Mitoxantrone—breast cancer	0.000203	0.000203	CcSEcCtD
Meropenem—Dermatitis—Mitoxantrone—breast cancer	0.000202	0.000202	CcSEcCtD
Meropenem—Dermatitis—Irinotecan—breast cancer	0.000202	0.000202	CcSEcCtD
Meropenem—Chills—Methotrexate—breast cancer	0.000202	0.000202	CcSEcCtD
Meropenem—Headache—Irinotecan—breast cancer	0.000201	0.000201	CcSEcCtD
Meropenem—Headache—Mitoxantrone—breast cancer	0.000201	0.000201	CcSEcCtD
Meropenem—Hypotension—Capecitabine—breast cancer	0.000201	0.000201	CcSEcCtD
Meropenem—Insomnia—Docetaxel—breast cancer	0.000201	0.000201	CcSEcCtD
Meropenem—Paraesthesia—Docetaxel—breast cancer	0.000199	0.000199	CcSEcCtD
Meropenem—Erythema multiforme—Epirubicin—breast cancer	0.000199	0.000199	CcSEcCtD
Meropenem—Vomiting—Gemcitabine—breast cancer	0.000199	0.000199	CcSEcCtD
Meropenem—Bradycardia—Doxorubicin—breast cancer	0.000199	0.000199	CcSEcCtD
Meropenem—Dyspnoea—Docetaxel—breast cancer	0.000198	0.000198	CcSEcCtD
Meropenem—Somnolence—Docetaxel—breast cancer	0.000197	0.000197	CcSEcCtD
Meropenem—Rash—Gemcitabine—breast cancer	0.000197	0.000197	CcSEcCtD
Meropenem—Dermatitis—Gemcitabine—breast cancer	0.000197	0.000197	CcSEcCtD
Meropenem—Erythema—Methotrexate—breast cancer	0.000196	0.000196	CcSEcCtD
Meropenem—Haemoglobin—Doxorubicin—breast cancer	0.000196	0.000196	CcSEcCtD
Meropenem—Headache—Gemcitabine—breast cancer	0.000196	0.000196	CcSEcCtD
Meropenem—Vomiting—Fluorouracil—breast cancer	0.000196	0.000196	CcSEcCtD
Meropenem—Dyspepsia—Docetaxel—breast cancer	0.000196	0.000196	CcSEcCtD
Meropenem—Hepatitis—Doxorubicin—breast cancer	0.000195	0.000195	CcSEcCtD
Meropenem—Haemorrhage—Doxorubicin—breast cancer	0.000195	0.000195	CcSEcCtD
Meropenem—Insomnia—Capecitabine—breast cancer	0.000195	0.000195	CcSEcCtD
Meropenem—Rash—Fluorouracil—breast cancer	0.000194	0.000194	CcSEcCtD
Meropenem—Dermatitis—Fluorouracil—breast cancer	0.000194	0.000194	CcSEcCtD
Meropenem—Pharyngitis—Doxorubicin—breast cancer	0.000194	0.000194	CcSEcCtD
Meropenem—Paraesthesia—Capecitabine—breast cancer	0.000193	0.000193	CcSEcCtD
Meropenem—Decreased appetite—Docetaxel—breast cancer	0.000193	0.000193	CcSEcCtD
Meropenem—Hypersensitivity—Paclitaxel—breast cancer	0.000193	0.000193	CcSEcCtD
Meropenem—Headache—Fluorouracil—breast cancer	0.000193	0.000193	CcSEcCtD
Meropenem—Oedema peripheral—Doxorubicin—breast cancer	0.000192	0.000192	CcSEcCtD
Meropenem—Dysgeusia—Methotrexate—breast cancer	0.000192	0.000192	CcSEcCtD
Meropenem—Gastrointestinal disorder—Docetaxel—breast cancer	0.000192	0.000192	CcSEcCtD
Meropenem—Dyspnoea—Capecitabine—breast cancer	0.000192	0.000192	CcSEcCtD
Meropenem—Nausea—Mitoxantrone—breast cancer	0.000191	0.000191	CcSEcCtD
Meropenem—Nausea—Irinotecan—breast cancer	0.000191	0.000191	CcSEcCtD
Meropenem—Immune system disorder—Epirubicin—breast cancer	0.00019	0.00019	CcSEcCtD
Meropenem—Pain—Docetaxel—breast cancer	0.00019	0.00019	CcSEcCtD
Meropenem—Constipation—Docetaxel—breast cancer	0.00019	0.00019	CcSEcCtD
Meropenem—Back pain—Methotrexate—breast cancer	0.00019	0.00019	CcSEcCtD
Meropenem—Dyspepsia—Capecitabine—breast cancer	0.000189	0.000189	CcSEcCtD
Meropenem—Chills—Epirubicin—breast cancer	0.000189	0.000189	CcSEcCtD
Meropenem—Asthenia—Paclitaxel—breast cancer	0.000188	0.000188	CcSEcCtD
Meropenem—Decreased appetite—Capecitabine—breast cancer	0.000187	0.000187	CcSEcCtD
Meropenem—Nausea—Gemcitabine—breast cancer	0.000186	0.000186	CcSEcCtD
Meropenem—Gastrointestinal disorder—Capecitabine—breast cancer	0.000186	0.000186	CcSEcCtD
Meropenem—Pruritus—Paclitaxel—breast cancer	0.000185	0.000185	CcSEcCtD
Meropenem—Erythema multiforme—Doxorubicin—breast cancer	0.000184	0.000184	CcSEcCtD
Meropenem—Pain—Capecitabine—breast cancer	0.000184	0.000184	CcSEcCtD
Meropenem—Constipation—Capecitabine—breast cancer	0.000184	0.000184	CcSEcCtD
Meropenem—Erythema—Epirubicin—breast cancer	0.000184	0.000184	CcSEcCtD
Meropenem—Feeling abnormal—Docetaxel—breast cancer	0.000183	0.000183	CcSEcCtD
Meropenem—Nausea—Fluorouracil—breast cancer	0.000183	0.000183	CcSEcCtD
Meropenem—Gastrointestinal pain—Docetaxel—breast cancer	0.000182	0.000182	CcSEcCtD
Meropenem—Anaemia—Methotrexate—breast cancer	0.000181	0.000181	CcSEcCtD
Meropenem—Flatulence—Epirubicin—breast cancer	0.000181	0.000181	CcSEcCtD
Meropenem—Tension—Epirubicin—breast cancer	0.00018	0.00018	CcSEcCtD
Meropenem—Dysgeusia—Epirubicin—breast cancer	0.00018	0.00018	CcSEcCtD
Meropenem—Diarrhoea—Paclitaxel—breast cancer	0.000179	0.000179	CcSEcCtD
Meropenem—Nervousness—Epirubicin—breast cancer	0.000178	0.000178	CcSEcCtD
Meropenem—Back pain—Epirubicin—breast cancer	0.000178	0.000178	CcSEcCtD
Meropenem—Feeling abnormal—Capecitabine—breast cancer	0.000177	0.000177	CcSEcCtD
Meropenem—Malaise—Methotrexate—breast cancer	0.000177	0.000177	CcSEcCtD
Meropenem—Immune system disorder—Doxorubicin—breast cancer	0.000176	0.000176	CcSEcCtD
Meropenem—Gastrointestinal pain—Capecitabine—breast cancer	0.000176	0.000176	CcSEcCtD
Meropenem—Abdominal pain—Docetaxel—breast cancer	0.000176	0.000176	CcSEcCtD
Meropenem—Body temperature increased—Docetaxel—breast cancer	0.000176	0.000176	CcSEcCtD
Meropenem—Leukopenia—Methotrexate—breast cancer	0.000176	0.000176	CcSEcCtD
Meropenem—Chills—Doxorubicin—breast cancer	0.000175	0.000175	CcSEcCtD
Meropenem—Dizziness—Paclitaxel—breast cancer	0.000173	0.000173	CcSEcCtD
Meropenem—Cough—Methotrexate—breast cancer	0.000171	0.000171	CcSEcCtD
Meropenem—Urticaria—Capecitabine—breast cancer	0.000171	0.000171	CcSEcCtD
Meropenem—Body temperature increased—Capecitabine—breast cancer	0.00017	0.00017	CcSEcCtD
Meropenem—Abdominal pain—Capecitabine—breast cancer	0.00017	0.00017	CcSEcCtD
Meropenem—Erythema—Doxorubicin—breast cancer	0.00017	0.00017	CcSEcCtD
Meropenem—Anaemia—Epirubicin—breast cancer	0.00017	0.00017	CcSEcCtD
Meropenem—Agitation—Epirubicin—breast cancer	0.000169	0.000169	CcSEcCtD
Meropenem—Flatulence—Doxorubicin—breast cancer	0.000167	0.000167	CcSEcCtD
Meropenem—Chest pain—Methotrexate—breast cancer	0.000167	0.000167	CcSEcCtD
Meropenem—Tension—Doxorubicin—breast cancer	0.000167	0.000167	CcSEcCtD
Meropenem—Vomiting—Paclitaxel—breast cancer	0.000167	0.000167	CcSEcCtD
Meropenem—Dysgeusia—Doxorubicin—breast cancer	0.000166	0.000166	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—breast cancer	0.000166	0.000166	CcSEcCtD
Meropenem—Malaise—Epirubicin—breast cancer	0.000166	0.000166	CcSEcCtD
Meropenem—Rash—Paclitaxel—breast cancer	0.000165	0.000165	CcSEcCtD
Meropenem—Dermatitis—Paclitaxel—breast cancer	0.000165	0.000165	CcSEcCtD
Meropenem—Nervousness—Doxorubicin—breast cancer	0.000165	0.000165	CcSEcCtD
Meropenem—Syncope—Epirubicin—breast cancer	0.000165	0.000165	CcSEcCtD
Meropenem—Leukopenia—Epirubicin—breast cancer	0.000164	0.000164	CcSEcCtD
Meropenem—Back pain—Doxorubicin—breast cancer	0.000164	0.000164	CcSEcCtD
Meropenem—Headache—Paclitaxel—breast cancer	0.000164	0.000164	CcSEcCtD
Meropenem—Hypersensitivity—Docetaxel—breast cancer	0.000164	0.000164	CcSEcCtD
Meropenem—Confusional state—Methotrexate—breast cancer	0.000161	0.000161	CcSEcCtD
Meropenem—Loss of consciousness—Epirubicin—breast cancer	0.000161	0.000161	CcSEcCtD
Meropenem—Cough—Epirubicin—breast cancer	0.00016	0.00016	CcSEcCtD
Meropenem—Anaphylactic shock—Methotrexate—breast cancer	0.00016	0.00016	CcSEcCtD
Meropenem—Asthenia—Docetaxel—breast cancer	0.000159	0.000159	CcSEcCtD
Meropenem—Infection—Methotrexate—breast cancer	0.000159	0.000159	CcSEcCtD
Meropenem—Hypertension—Epirubicin—breast cancer	0.000158	0.000158	CcSEcCtD
Meropenem—Hypersensitivity—Capecitabine—breast cancer	0.000158	0.000158	CcSEcCtD
Meropenem—Pruritus—Docetaxel—breast cancer	0.000157	0.000157	CcSEcCtD
Meropenem—Nervous system disorder—Methotrexate—breast cancer	0.000157	0.000157	CcSEcCtD
Meropenem—Anaemia—Doxorubicin—breast cancer	0.000157	0.000157	CcSEcCtD
Meropenem—Thrombocytopenia—Methotrexate—breast cancer	0.000157	0.000157	CcSEcCtD
Meropenem—Chest pain—Epirubicin—breast cancer	0.000156	0.000156	CcSEcCtD
Meropenem—Agitation—Doxorubicin—breast cancer	0.000156	0.000156	CcSEcCtD
Meropenem—Anxiety—Epirubicin—breast cancer	0.000156	0.000156	CcSEcCtD
Meropenem—Nausea—Paclitaxel—breast cancer	0.000156	0.000156	CcSEcCtD
Meropenem—Skin disorder—Methotrexate—breast cancer	0.000156	0.000156	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—breast cancer	0.000155	0.000155	CcSEcCtD
Meropenem—Hyperhidrosis—Methotrexate—breast cancer	0.000155	0.000155	CcSEcCtD
Meropenem—Asthenia—Capecitabine—breast cancer	0.000154	0.000154	CcSEcCtD
Meropenem—Malaise—Doxorubicin—breast cancer	0.000153	0.000153	CcSEcCtD
Meropenem—Anorexia—Methotrexate—breast cancer	0.000153	0.000153	CcSEcCtD
Meropenem—Syncope—Doxorubicin—breast cancer	0.000152	0.000152	CcSEcCtD
Meropenem—Pruritus—Capecitabine—breast cancer	0.000152	0.000152	CcSEcCtD
Meropenem—Leukopenia—Doxorubicin—breast cancer	0.000152	0.000152	CcSEcCtD
Meropenem—Diarrhoea—Docetaxel—breast cancer	0.000152	0.000152	CcSEcCtD
Meropenem—Confusional state—Epirubicin—breast cancer	0.000151	0.000151	CcSEcCtD
Meropenem—Oedema—Epirubicin—breast cancer	0.00015	0.00015	CcSEcCtD
Meropenem—Anaphylactic shock—Epirubicin—breast cancer	0.00015	0.00015	CcSEcCtD
Meropenem—Hypotension—Methotrexate—breast cancer	0.00015	0.00015	CcSEcCtD
Meropenem—Loss of consciousness—Doxorubicin—breast cancer	0.000149	0.000149	CcSEcCtD
Meropenem—Infection—Epirubicin—breast cancer	0.000149	0.000149	CcSEcCtD
Meropenem—Cough—Doxorubicin—breast cancer	0.000148	0.000148	CcSEcCtD
Meropenem—Shock—Epirubicin—breast cancer	0.000147	0.000147	CcSEcCtD
Meropenem—Diarrhoea—Capecitabine—breast cancer	0.000147	0.000147	CcSEcCtD
Meropenem—Nervous system disorder—Epirubicin—breast cancer	0.000147	0.000147	CcSEcCtD
Meropenem—Dizziness—Docetaxel—breast cancer	0.000147	0.000147	CcSEcCtD
Meropenem—Thrombocytopenia—Epirubicin—breast cancer	0.000147	0.000147	CcSEcCtD
Meropenem—Hypertension—Doxorubicin—breast cancer	0.000147	0.000147	CcSEcCtD
Meropenem—Tachycardia—Epirubicin—breast cancer	0.000146	0.000146	CcSEcCtD
Meropenem—Skin disorder—Epirubicin—breast cancer	0.000146	0.000146	CcSEcCtD
Meropenem—Hyperhidrosis—Epirubicin—breast cancer	0.000145	0.000145	CcSEcCtD
Meropenem—Insomnia—Methotrexate—breast cancer	0.000145	0.000145	CcSEcCtD
Meropenem—Chest pain—Doxorubicin—breast cancer	0.000145	0.000145	CcSEcCtD
Meropenem—Anxiety—Doxorubicin—breast cancer	0.000144	0.000144	CcSEcCtD
Meropenem—Paraesthesia—Methotrexate—breast cancer	0.000144	0.000144	CcSEcCtD
Meropenem—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—breast cancer	0.000144	0.000144	CcSEcCtD
Meropenem—Anorexia—Epirubicin—breast cancer	0.000143	0.000143	CcSEcCtD
Meropenem—Dyspnoea—Methotrexate—breast cancer	0.000143	0.000143	CcSEcCtD
Meropenem—Somnolence—Methotrexate—breast cancer	0.000142	0.000142	CcSEcCtD
Meropenem—Dizziness—Capecitabine—breast cancer	0.000142	0.000142	CcSEcCtD
Meropenem—Vomiting—Docetaxel—breast cancer	0.000141	0.000141	CcSEcCtD
Meropenem—Dyspepsia—Methotrexate—breast cancer	0.000141	0.000141	CcSEcCtD
Meropenem—Rash—Docetaxel—breast cancer	0.00014	0.00014	CcSEcCtD
Meropenem—Hypotension—Epirubicin—breast cancer	0.00014	0.00014	CcSEcCtD
Meropenem—Dermatitis—Docetaxel—breast cancer	0.00014	0.00014	CcSEcCtD
Meropenem—Confusional state—Doxorubicin—breast cancer	0.00014	0.00014	CcSEcCtD
Meropenem—Decreased appetite—Methotrexate—breast cancer	0.000139	0.000139	CcSEcCtD
Meropenem—Headache—Docetaxel—breast cancer	0.000139	0.000139	CcSEcCtD
Meropenem—Anaphylactic shock—Doxorubicin—breast cancer	0.000139	0.000139	CcSEcCtD
Meropenem—Oedema—Doxorubicin—breast cancer	0.000139	0.000139	CcSEcCtD
Meropenem—Gastrointestinal disorder—Methotrexate—breast cancer	0.000138	0.000138	CcSEcCtD
Meropenem—Infection—Doxorubicin—breast cancer	0.000138	0.000138	CcSEcCtD
Meropenem—Pain—Methotrexate—breast cancer	0.000137	0.000137	CcSEcCtD
Meropenem—Vomiting—Capecitabine—breast cancer	0.000137	0.000137	CcSEcCtD
Meropenem—Shock—Doxorubicin—breast cancer	0.000136	0.000136	CcSEcCtD
Meropenem—Nervous system disorder—Doxorubicin—breast cancer	0.000136	0.000136	CcSEcCtD
Meropenem—Thrombocytopenia—Doxorubicin—breast cancer	0.000136	0.000136	CcSEcCtD
Meropenem—Rash—Capecitabine—breast cancer	0.000136	0.000136	CcSEcCtD
Meropenem—Insomnia—Epirubicin—breast cancer	0.000136	0.000136	CcSEcCtD
Meropenem—Dermatitis—Capecitabine—breast cancer	0.000135	0.000135	CcSEcCtD
Meropenem—Tachycardia—Doxorubicin—breast cancer	0.000135	0.000135	CcSEcCtD
Meropenem—Headache—Capecitabine—breast cancer	0.000135	0.000135	CcSEcCtD
Meropenem—Skin disorder—Doxorubicin—breast cancer	0.000135	0.000135	CcSEcCtD
Meropenem—Paraesthesia—Epirubicin—breast cancer	0.000135	0.000135	CcSEcCtD
Meropenem—Hyperhidrosis—Doxorubicin—breast cancer	0.000134	0.000134	CcSEcCtD
Meropenem—Dyspnoea—Epirubicin—breast cancer	0.000134	0.000134	CcSEcCtD
Meropenem—Somnolence—Epirubicin—breast cancer	0.000133	0.000133	CcSEcCtD
Meropenem—Anorexia—Doxorubicin—breast cancer	0.000132	0.000132	CcSEcCtD
Meropenem—Nausea—Docetaxel—breast cancer	0.000132	0.000132	CcSEcCtD
Meropenem—Feeling abnormal—Methotrexate—breast cancer	0.000132	0.000132	CcSEcCtD
Meropenem—Dyspepsia—Epirubicin—breast cancer	0.000132	0.000132	CcSEcCtD
Meropenem—Gastrointestinal pain—Methotrexate—breast cancer	0.000131	0.000131	CcSEcCtD
Meropenem—Decreased appetite—Epirubicin—breast cancer	0.00013	0.00013	CcSEcCtD
Meropenem—Hypotension—Doxorubicin—breast cancer	0.00013	0.00013	CcSEcCtD
Meropenem—Gastrointestinal disorder—Epirubicin—breast cancer	0.000129	0.000129	CcSEcCtD
Meropenem—Pain—Epirubicin—breast cancer	0.000128	0.000128	CcSEcCtD
Meropenem—Constipation—Epirubicin—breast cancer	0.000128	0.000128	CcSEcCtD
Meropenem—Nausea—Capecitabine—breast cancer	0.000128	0.000128	CcSEcCtD
Meropenem—Urticaria—Methotrexate—breast cancer	0.000127	0.000127	CcSEcCtD
Meropenem—Body temperature increased—Methotrexate—breast cancer	0.000127	0.000127	CcSEcCtD
Meropenem—Abdominal pain—Methotrexate—breast cancer	0.000127	0.000127	CcSEcCtD
Meropenem—Insomnia—Doxorubicin—breast cancer	0.000125	0.000125	CcSEcCtD
Meropenem—Paraesthesia—Doxorubicin—breast cancer	0.000124	0.000124	CcSEcCtD
Meropenem—Dyspnoea—Doxorubicin—breast cancer	0.000124	0.000124	CcSEcCtD
Meropenem—Feeling abnormal—Epirubicin—breast cancer	0.000123	0.000123	CcSEcCtD
Meropenem—Somnolence—Doxorubicin—breast cancer	0.000123	0.000123	CcSEcCtD
Meropenem—Gastrointestinal pain—Epirubicin—breast cancer	0.000123	0.000123	CcSEcCtD
Meropenem—Dyspepsia—Doxorubicin—breast cancer	0.000122	0.000122	CcSEcCtD
Meropenem—Decreased appetite—Doxorubicin—breast cancer	0.000121	0.000121	CcSEcCtD
Meropenem—Gastrointestinal disorder—Doxorubicin—breast cancer	0.00012	0.00012	CcSEcCtD
Meropenem—Urticaria—Epirubicin—breast cancer	0.000119	0.000119	CcSEcCtD
Meropenem—Constipation—Doxorubicin—breast cancer	0.000119	0.000119	CcSEcCtD
Meropenem—Pain—Doxorubicin—breast cancer	0.000119	0.000119	CcSEcCtD
Meropenem—Abdominal pain—Epirubicin—breast cancer	0.000118	0.000118	CcSEcCtD
Meropenem—Body temperature increased—Epirubicin—breast cancer	0.000118	0.000118	CcSEcCtD
Meropenem—Hypersensitivity—Methotrexate—breast cancer	0.000118	0.000118	CcSEcCtD
Meropenem—Asthenia—Methotrexate—breast cancer	0.000115	0.000115	CcSEcCtD
Meropenem—Feeling abnormal—Doxorubicin—breast cancer	0.000114	0.000114	CcSEcCtD
Meropenem—Gastrointestinal pain—Doxorubicin—breast cancer	0.000113	0.000113	CcSEcCtD
Meropenem—Pruritus—Methotrexate—breast cancer	0.000113	0.000113	CcSEcCtD
Meropenem—Hypersensitivity—Epirubicin—breast cancer	0.00011	0.00011	CcSEcCtD
Meropenem—Urticaria—Doxorubicin—breast cancer	0.00011	0.00011	CcSEcCtD
Meropenem—Abdominal pain—Doxorubicin—breast cancer	0.00011	0.00011	CcSEcCtD
Meropenem—Body temperature increased—Doxorubicin—breast cancer	0.00011	0.00011	CcSEcCtD
Meropenem—Diarrhoea—Methotrexate—breast cancer	0.00011	0.00011	CcSEcCtD
Meropenem—Asthenia—Epirubicin—breast cancer	0.000107	0.000107	CcSEcCtD
Meropenem—Pruritus—Epirubicin—breast cancer	0.000106	0.000106	CcSEcCtD
Meropenem—Dizziness—Methotrexate—breast cancer	0.000106	0.000106	CcSEcCtD
Meropenem—Diarrhoea—Epirubicin—breast cancer	0.000103	0.000103	CcSEcCtD
Meropenem—Hypersensitivity—Doxorubicin—breast cancer	0.000102	0.000102	CcSEcCtD
Meropenem—Vomiting—Methotrexate—breast cancer	0.000102	0.000102	CcSEcCtD
Meropenem—Rash—Methotrexate—breast cancer	0.000101	0.000101	CcSEcCtD
Meropenem—Dermatitis—Methotrexate—breast cancer	0.000101	0.000101	CcSEcCtD
Meropenem—Headache—Methotrexate—breast cancer	0.0001	0.0001	CcSEcCtD
Meropenem—Asthenia—Doxorubicin—breast cancer	9.95e-05	9.95e-05	CcSEcCtD
Meropenem—Dizziness—Epirubicin—breast cancer	9.91e-05	9.91e-05	CcSEcCtD
Meropenem—Pruritus—Doxorubicin—breast cancer	9.81e-05	9.81e-05	CcSEcCtD
Meropenem—Vomiting—Epirubicin—breast cancer	9.53e-05	9.53e-05	CcSEcCtD
Meropenem—Nausea—Methotrexate—breast cancer	9.51e-05	9.51e-05	CcSEcCtD
Meropenem—Diarrhoea—Doxorubicin—breast cancer	9.49e-05	9.49e-05	CcSEcCtD
Meropenem—Rash—Epirubicin—breast cancer	9.45e-05	9.45e-05	CcSEcCtD
Meropenem—Dermatitis—Epirubicin—breast cancer	9.44e-05	9.44e-05	CcSEcCtD
Meropenem—Headache—Epirubicin—breast cancer	9.39e-05	9.39e-05	CcSEcCtD
Meropenem—Dizziness—Doxorubicin—breast cancer	9.17e-05	9.17e-05	CcSEcCtD
Meropenem—Nausea—Epirubicin—breast cancer	8.9e-05	8.9e-05	CcSEcCtD
Meropenem—Vomiting—Doxorubicin—breast cancer	8.81e-05	8.81e-05	CcSEcCtD
Meropenem—Rash—Doxorubicin—breast cancer	8.74e-05	8.74e-05	CcSEcCtD
Meropenem—Dermatitis—Doxorubicin—breast cancer	8.73e-05	8.73e-05	CcSEcCtD
Meropenem—Headache—Doxorubicin—breast cancer	8.68e-05	8.68e-05	CcSEcCtD
Meropenem—Nausea—Doxorubicin—breast cancer	8.23e-05	8.23e-05	CcSEcCtD
